Related Experiment Video

Updated: Aug 14, 2026

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Evolving strategies for renal tumor surgery: whether by open or by laparoscopic approaches, do the right operation!

Paul Russo

    Urologic Oncology
    |November 23, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 14, 2026

    Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
    06:39

    Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

    Published on: November 22, 2019

    Related Concept Videos

    Kidney Transplant II: Surgical Procedure01:26

    Kidney Transplant II: Surgical Procedure

    Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
    Urinary Tract Calculi VI: Surgical Management01:25

    Urinary Tract Calculi VI: Surgical Management

    Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

    Articles linked to this work by shared authors, journal, and citation graph.

    Complete response to dual immune checkpoint blockade in a patient with Birt-Hogg-Dubé syndrome and epithelioid angiomyolipoma.

    Journal for immunotherapy of cancer·2026

    Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma.

    Cancer cell·2026

    Long-term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma.

    BJUI compass·2026

    Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.

    Cancers·2025

    Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center Experience.

    Clinical genitourinary cancer·2025

    Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.

    European urology oncology·2025

    Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

    Urologic oncology·2026

    FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.

    Urologic oncology·2026

    Intraoperative indocyanine green fluorescence guidance to reduce ureteroenteric anastomotic strictures during robot-assisted radical cystectomy. A systematic review and meta-analysis.

    Urologic oncology·2026

    Prostate lymphoma uncovered during urological encounters: Diagnostic challenges and clinical outcomes in a case series with systematic review of the literature.

    Urologic oncology·2026

    Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer.

    Urologic oncology·2026

    Therapeutic landscape of upper tract urothelial carcinoma: Intraluminal agents, perioperative chemotherapy, and immunotherapy.

    Urologic oncology·2026

    Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

    Cell cycle (Georgetown, Tex.)·2026

    Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

    Aging medicine (Milton (N.S.W))·2026

    Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

    International journal of nanomedicine·2026

    Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

    International journal of pharmaceutics: X·2026

    Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

    Materials today. Bio·2026

    Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

    Materials today. Bio·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us